Warning
Central Admixture Pharmacy Services Recalls TPN bag (patient specific)
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0524-2026Drug / Pharmaceutical
Central Admixture Pharmacy Services Recalls TPN bag (patient specific)
Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles · Class II — Moderate Risk
Product Description
TPN bag (patient specific), Rx# 11-4909703-0-1, Compound Volume 1660 mL per bag, Rx only, Single Dose Injection, Refrigerated Injection, Central Admixture Pharmacy Services, Los Angeles, 13128 Imperial Hwy, Santa Fe Spr., CA 90670
Reason for Recall
Incorrect Product Formulation: product did not contain insulin as listed in the label.
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
CA
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
A Class II FDA recall has been issued for a pharmaceutical product from Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles, initiated on December 27, 2025. Incorrect Product Formulation: product did not contain insulin as listed in the label. This recall covers 1 bag, distributed in CA. While not the highest severity, consumers should exercise caution and stop using the product until the recall is resolved.
Sources: FDA openFDA Enforcement Database
This recall appears in: Other Injury Hazards.